Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.811.131.321.160.93

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.81 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.81
Mar20231.13
Mar20221.32
Mar20211.16
Mar20200.93

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32
13.79
Mar2021 1.16
24.73
Mar2020 0.93 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,926.6 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses